Destiny Pharma secures £1.6m grant to fight ‘superbugs’ and antimicrobial resistance
January 29, 2019Manufacturing and Production, Research and Development Destiny Pharma, antimicrobial resistance, pharma
UK biotech Destiny Pharma has secured £1.6 million in funding to further its research into the prevention and elimination of …
Edinburgh researchers genetically modify chickens to produce medicine filled eggs
January 29, 2019Manufacturing and Production Edinburgh, cancer drugs, medicines, monoclonal antibodies, proteins
Researchers at the University of Edinburgh have genetically modified chickens, meaning that they lay eggs containing human proteins which can …
Alexander Hardy returns to Genentech as new CEO
January 28, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Genentech, Roche, appointment, pharma
Genetech, the biotech subsidiary of Swiss firm Roche, has named its new CEO, revealing that Alexander Hardy will be returning …
Philip Hampton to step down from chairman role at GSK
January 28, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, UK, appointment, pharma
Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just …
Novartis warns of huge impact of no-deal Brexit
January 28, 2019Sales and Marketing EU, Novartis, UK, brexit, no-deal, pharma
Swiss pharmaceutical company Novartis has called on the British government to ‘ensure continuity of supply’ in the case of a …
Head of opioid advisory panel criticises FDA for complacency in ongoing crisis
January 28, 2019Medical Communications, Sales and Marketing Dsuvia, FDA, opioid crisis, opioids, pharma
The opioid crisis continues to be a top healthcare concern in the US, but the head of the FDA’s Anesthetic …
People in England will be able to pay the NHS to sequence their genetic data, if they share it with scientists
January 28, 2019Sales and Marketing Alzheimer's, Cancer, England, NHS, genetic data, genomes, health
The NHS will provide paid-for health reports, informing patients as to the likelihood that they will develop diseases such as …
Allergan and St Regis Mohawk Tribe take patent ruling to Supreme Court
January 28, 2019Sales and Marketing Allergan, Mohawk, Restasis, St Regis, eye drops, patents
Allergan and the St Regis Mohawk Tribe have asked the Supreme Court to defend a 2017 patent agreement which would …
Top Ten most popular articles on Pharmafile.com this week!
January 25, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Celgene, NHS, health, pharma, venlytxo
While American firm AbbVie gained approval for leukaemia drug Venlytxo, the NHS defeated the US multinational thus week in court, …
Bristol-Myers Squibb withdraws lung cancer combo therapy marketing application
January 25, 2019Medical Communications BMS, Merck, Yervoy, ctla4, lung cancer, opdivo
Bristol-Myers Squibb has been forced to withdraw a marketing application for its combination of Opdivo and Yervoy for lung cancer. …
China’s NMPA approves Amgen’s Repatha to reduce cardiovascular event risk
January 25, 2019Medical Communications, Sales and Marketing Amgen, China, Repatha, cardiovascular disease, pharma, stroke
Amgen has announced that its proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor Repatha (evolocumab) has secured approval by China’s drug …
Diagnosis at stages 1-3 increases cancer survival rate significantly
January 25, 2019Medical Communications Cancer, England, NHS, health, oncology
Adults diagnosed with stage 1 skin, prostate or breast cancer have the same chance of still being alive the following …
NHS App begins public rollout across England following successful testing
January 24, 2019Medical Communications England, NHS, NHS App, UK, health, pharma
NHS England has announced that the NHS app, which will allow patients to book and manage their GP appointments alongside …
UK government launches plan to control AMR by 2040
January 24, 2019Medical Communications, Research and Development AMR, Antibiotics, Davos, Matt Hancock, UK
The British government has announced a plan through which it will incentivise pharmaceutical companies to develop drugs aimed at tackling …
EMA rejects Lilly’s Lartruvo in soft tissue cancer following trial failure
January 24, 2019Sales and Marketing Cancer, EMA, Eli Lilly, Lartruvo, pharma
Eli Lilly has been dealt a blow as the European Medicines Agency announced its recommendation for soft tissue cancer patients …
Vertex ousts COO Ian Smith over ‘personal behaviour’
January 24, 2019Business Services Ian Smith, Jobs, Vertex, executives
Boston-based firm Vertex Pharmaceuticals has fired Chief Operating Officer (COO) and interim Chief Financial Officer (CFO) Ian Smith. Smith’s termination, …
Irish Pfizer employees to launch industrial action ballot over pensions scheme
January 24, 2019Manufacturing and Production Ireladn, Pfizer, cork, industrial action, manufacturing, strike
Pfizer employees have rejected a Labour Court recommendation regarding their pension scheme, opting to initiate a ballot over potential industrial …
Cost of insulin doubled between 2012 and 2016
January 23, 2019Research and Development USA, healthcare, insulin, insurance, pricing
The cost of insulin almost doubled in the United States between 2012 and 2016, according to a report by the …
GSK acquires oncology firm Tesaro for $5.1 billion
January 23, 2019Research and Development Cancer, GSK, Tesaro, oncology, ovarian cancer
British multinational GlaxoSmithKline (GSK) have acquired US oncology firm Tesaro for $5.1 billion (£4 billion). Tesaro, a Massachusetts-based clinical stage …
NICE recommend digital CBT for young people with mild depression
January 23, 2019Research and Development CBT, Digital CBT, NHS, psychology, psychotherapy
Britain’s cost effectiveness body NICE has recommended digital Cognitive Behavioural Therapy (CBT) for children with mild depression as a first …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
